Nature Science Technologies

Nature Science Technologies is a Latvian-based startup founded in 2017, specializing in the production and development of small-scale supply and custom syntheses of betulin derivatives for drug discovery and medicinal chemistry. Their product portfolio consists of over 20 high-quality semi-synthetic betulin derivatives, including amine, alkyne, and azide derivatives of betulin, betulinic acid, and betulonic acid. These derivatives are produced from betulin, sourced from nature, and are available for purchase for research and development purposes. This pharmaceutical-focused startup offers an array of betulin derivatives crucial for R&D in drug discovery and medicinal chemistry. Despite the lack of specific information on the last investment, Nature Science Technologies presents a promising opportunity for venture capital. With a strong emphasis on high-quality products and an essential role in pharmaceutical research, investors looking for opportunities in the pharmaceutical industry will find this startup intriguing. The innovative approach to sourcing betulin from nature and producing valuable derivatives positions Nature Science Technologies as a potential venture for investment. However, further information on their growth trajectory and market demand would be essential to evaluate its potential for sustained success. Overall, this Latvian-based startup offers an interesting investment opportunity within the pharmaceutical industry with its focus on betulin derivatives for R&D.